Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma.

MLA

Hölzl, Dorothee, et al. “Integrated Analysis of Programmed Cell Death Ligand 1 Expression Reveals Increased Levels in High-Grade Glioma.” Journal of Cancer Research & Clinical Oncology, vol. 147, no. 8, Aug. 2021, pp. 2271–80. EBSCOhost, https://doi.org/10.1007/s00432-021-03656-w.

APA

Hölzl, D., Hutarew, G., Zellinger, B., Schlicker, H. U., Schwartz, C., Winkler, P. A., Sotlar, K., & Kraus, T. F. J. (2021). Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma. Journal of Cancer Research & Clinical Oncology, 147(8), 2271–2280. https://doi.org/10.1007/s00432-021-03656-w

Chicago

Hölzl, Dorothee, Georg Hutarew, Barbara Zellinger, Hans U. Schlicker, Christoph Schwartz, Peter A. Winkler, Karl Sotlar, and Theo F. J. Kraus. 2021. “Integrated Analysis of Programmed Cell Death Ligand 1 Expression Reveals Increased Levels in High-Grade Glioma.” Journal of Cancer Research & Clinical Oncology 147 (8): 2271–80. doi:10.1007/s00432-021-03656-w.